20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
- VBI Vaccines Inc (NASDAQ: VBIV) has announced an agreement to draw down a $12 million second tranche under its previously announced debt financing facility with K2 HealthVentures (K2HV).
- Under the terms of the debt financing facility, dated May 22, K2HV agreed to provide the Company up to $52 million in multiple tranches.
- The first tranche of $20 million was drawn upon the closing.
- The second tranche, upsized to $12 million from the initial $10 million, follows on achieving specific clinical milestones.
- Two additional tranches of up to $10 million each remain drawable in the future upon certain conditions.
- The first is contingent upon the achievement of a specified regulatory milestone, and the second and final tranche will be available at the discretion of K2HV.
- Price Action: VBIV shares are 0.47% at $3.21 on the last check Friday.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!